CNR1 and metabolic syndrome: Inhibition of CB1R activity improves the peripheral lipid profile and may start recovery from metabolic syndrome by decreasing body weight and appetite, thus also improving glucose and lipid homeostasis and preventing atherosclerosis [15,20,52].